CHRONIC HEPATITIS C TREATMENT IN 2015
DOI:
https://doi.org/10.52206/jsmc.2014.4.2.482Abstract
On a national level over 5% of the population is
estimated to be infected with the hepatitis C virus
(HCV), which corresponds to a prevalent
population of >70 million people with chronic
infection. For many patients who become
chronically infected, HCV causes slow,
progressive damage to the liver and represents one
of the leading causes of cirrhosis and
hepatocellular carcinoma (HCC).
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2021 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
